The U.K.'s National Health Service will no longer routinely prescribe puberty blockers to children over concerns about a lack of evidence on the impact from the drugs.
Consequently, the Full Committee business meeting, initially scheduled to vote on holding Director Wray in contempt of Congress on Thursday, has been canceled.
